Iowa Approach LLC is developing patent pending ablation catheters that will transform the surgical treatment of atrial fibrillation. Currently, there are ~60k atrial fibrillation ablation procedures performed in the US each year. Existing catheter based ablation procedures are lengthy (4-6 hours), require expensive equipment such as imaging devices, and pose significant risks of complications. Iowa Approach would significantly reduce the cost and time of the procedure. With 3.03M Americans living with atrial fibrillation, the company promises to expand surgery-eligible patient population by being less invasive.